Chromocell to Present at the H.C. Wainwright 26th Annual Global Investment Conference
September 03, 2024 09:00 ET
|
Chromocell Therapeutics Corporation
FREEHOLD, N.J., Sept. 03, 2024 (GLOBE NEWSWIRE) -- Chromocell Therapeutics Corporation (“Chromocell”, or the “Company”), (NYSE American: CHRO), a pioneer in the development of non-opioid pain...
Chromocell Announces Stock Repurchase Plan
August 07, 2024 08:45 ET
|
Chromocell Therapeutics Corporation
FREEHOLD, N.J., Aug. 07, 2024 (GLOBE NEWSWIRE) -- Chromocell Therapeutics Corporation (“Chromocell”, or the “Company”), (NYSE American: CHRO), a pioneer in the development of non-opioid pain...